Abstract

Hepatitis B virus (HBV) is a major cause of morbidity and mortality worldwide. Although the United Kingdom (UK) prevalence of HBV is low, it is increasing. There is some evidence that the rate of infection is much higher in some populations living in Britain of non-white ethnicity or who were not born in Britain, compared with the British-born white population. We examined the prevalence of HBV infection in pregnant women through hepatitis B surface antigen (HBsAg) or e-antigen (HBeAg) in Birmingham UK between May 2004 and December 2008 and the effect of ethnicity on the relative risk of infection. There was a significant increase in the number of antenatal HBV infections detected over the study period from 106 cases in 2005 to 161 cases in 2008 (p=0.037). Women who define themselves as of black African, non-British white and Pakistani ethnicity had a markedly elevated rate of HBV infection (relative risk (RR): 11.25, 5.87 and 2.33 respectively) compared to the England average. Health organisations that serve populations with a high or increasing proportion of women originating from intermediate and high HBV prevalence areas of the world such as Africa, some parts of Europe and Asia, should anticipate a need for perinatal and postnatal prophylaxis to children born to HBV infected mothers.

Highlights

  • Hepatitis B virus (HBV) is a major cause of morbidity and mortality worldwide

  • Data on the prevalence of hepatitis B in the United Kingdom (UK) and the impact of migration patterns are limited, there is some evidence that the rate of infection is much higher in people not born in Britain or of non-white ethnicity compared with the British-born www.eurosurveillance.org white population reflecting the higher HBV prevalence in their countries of birth or family origin [3,4]

  • The number of cases of hepatitis B diagnosed through antenatal screening in Birmingham and Solihull increased over the period 2004–2008

Read more

Summary

Introduction

Hepatitis B virus (HBV) is a major cause of morbidity and mortality worldwide. It is estimated to have affected two billion people, 350 million of which have chronic infection [1]. Data on the prevalence of hepatitis B in the UK and the impact of migration patterns are limited, there is some evidence that the rate of infection is much higher in people not born in Britain or of non-white ethnicity compared with the British-born www.eurosurveillance.org white population reflecting the higher HBV prevalence in their countries of birth or family origin [3,4]. All pregnant women in the UK are offered HBV testing as part of the national antenatal screening programme for infectious diseases. Women are offered HBV testing at their first antenatal appointment, usually at 8–12 weeks of pregnancy

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call